应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
BNTX BioNTech SE
交易中 08-12 14:55:37 EDT
93.37
+0.57
+0.61%
最高
93.78
最低
92.00
成交量
33.36万
今开
92.26
昨收
92.80
日振幅
1.92%
总市值
234.55亿
流通市值
99.91亿
总股本
2.51亿
成交额
3,112万
换手率
0.31%
流通股本
1.07亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
BioNTech宣布管理层重大变动：Guido Oelkers将于2027年2月1日接任CEO
投资观察 · 08-04
BioNTech宣布管理层重大变动：Guido Oelkers将于2027年2月1日接任CEO
异动解读 | 财报显示净亏损超8亿欧元，BioNTech盘前大跌5.78%
异动解读 · 08-04
异动解读 | 财报显示净亏损超8亿欧元，BioNTech盘前大跌5.78%
BioNTech第二季度营收达1.056亿欧元
投资观察 · 08-04
BioNTech第二季度营收达1.056亿欧元
重点关注个股：Palantir、SpaceX、汇丰控股
投资观察 · 08-04
重点关注个股：Palantir、SpaceX、汇丰控股
财报前瞻 ｜BioNTech SE本季度营收预计增5.96%，机构观点偏正面
财报Agent · 07-28
财报前瞻 ｜BioNTech SE本季度营收预计增5.96%，机构观点偏正面
Arbutus Biopharma与Genevant在加拿大提起诉讼，寻求对辉瑞/BioNTech的禁令及损害赔偿
美股速递 · 07-16
Arbutus Biopharma与Genevant在加拿大提起诉讼，寻求对辉瑞/BioNTech的禁令及损害赔偿
凯茜·伍德在股价下跌之际加倍押注SpaceX，继续抛售AMD股票
老虎资讯综合 · 07-08
凯茜·伍德在股价下跌之际加倍押注SpaceX，继续抛售AMD股票
辉瑞与BioNTech新冠疫苗获授权，将为6个月至11岁儿童统一使用10微克剂量
美股速递 · 05-29
辉瑞与BioNTech新冠疫苗获授权，将为6个月至11岁儿童统一使用10微克剂量
辉瑞与BioNTech SE准备根据FDA建议并在获批后供应2026-2027新冠疫苗配方：简报文件
美股速递 · 05-28
辉瑞与BioNTech SE准备根据FDA建议并在获批后供应2026-2027新冠疫苗配方：简报文件
BioNTech首季营业亏损6.775亿欧元 营收逊于预期
投资观察 · 05-05
BioNTech首季营业亏损6.775亿欧元 营收逊于预期
异动解读 | BioNTech盘前大跌5.59%，因宣布关闭生产基地并转移疫苗生产
异动解读 · 05-05
异动解读 | BioNTech盘前大跌5.59%，因宣布关闭生产基地并转移疫苗生产
BioNTech宣布2026年新冠疫苗生产将全面移交辉瑞 德国本土不再设生产线
美股速递 · 05-05
BioNTech宣布2026年新冠疫苗生产将全面移交辉瑞 德国本土不再设生产线
BioNTech预计2029年全面实施成本削减措施后 每年将实现约5亿欧元经常性节约
美股速递 · 05-05
BioNTech预计2029年全面实施成本削减措施后 每年将实现约5亿欧元经常性节约
财报前瞻｜BioNTech SE本季度营收预计减5.87%，机构观点中性偏谨慎
财报Agent · 04-28
财报前瞻｜BioNTech SE本季度营收预计减5.87%，机构观点中性偏谨慎
Trastuzumab Pamirtecan在2期子宫内膜癌队列中达到主要疗效终点
投资观察 · 04-13
Trastuzumab Pamirtecan在2期子宫内膜癌队列中达到主要疗效终点
辉瑞和BioNTech停止在美国的一项新冠疫苗研究
格隆汇 · 04-02
辉瑞和BioNTech停止在美国的一项新冠疫苗研究
辉瑞与合作伙伴BioNTech宣布：因招募缓慢将终止美国50至64岁健康成年人新冠疫苗研究
美股速递 · 04-01
辉瑞与合作伙伴BioNTech宣布：因招募缓慢将终止美国50至64岁健康成年人新冠疫苗研究
BioNTech创始人将离职创立新的mRNA企业
环球市场播报 · 03-11
BioNTech创始人将离职创立新的mRNA企业
美股异动 | 2026年收入指引低于预期 BioNTech(BNTX.US)暴跌超20%
智通财经网 · 03-10
美股异动 | 2026年收入指引低于预期 BioNTech(BNTX.US)暴跌超20%
异动解读 | 创始人离职叠加业绩指引下调，BioNTech盘中暴跌21.54%
异动解读 · 03-10
异动解读 | 创始人离职叠加业绩指引下调，BioNTech盘中暴跌21.54%
加载更多
公司概况
公司名称：
BioNTech SE
所属市场：
NASDAQ
上市日期：
--
主营业务：
BioNTech SE成立于2008年6月2日。该公司结合了数十年的免疫学，尖端治疗平台以及各种患者分析和生物信息学工具的开创性研究，开发针对癌症和其他疾病的个体化免疫疗法。该公司利用强大的新治疗机制，利用各种生物学靶点，利用每位患者免疫系统的力量，解决每位患者潜在疾病的独特分子特征。
发行价格：
--
{"stockData":{"symbol":"BNTX","market":"US","secType":"STK","nameCN":"BioNTech SE","latestPrice":93.37,"timestamp":1786560935078,"preClose":92.8,"halted":0,"volume":333617,"delay":0,"changeRate":0.006142241379310425,"floatShares":107000000,"shares":251204366,"eps":-7.772625,"marketStatus":"交易中","change":0.57,"latestTime":"08-12 14:55:37 EDT","open":92.26,"high":93.78,"low":92,"amount":31117670.621411998,"amplitude":0.019181,"askPrice":93.46,"askSize":130,"bidPrice":93.37,"bidSize":131,"shortable":3,"etf":0,"ttmEps":-7.772625,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1786564800000},"marketStatusCode":2,"adr":0,"adrRate":1,"listingDate":1570680000000,"exchange":"NASDAQ","adjPreClose":92.8,"preHourTrading":{"tag":"盘前","latestPrice":92.19,"preClose":92.8,"latestTime":"09:29 EDT","volume":28,"amount":2588.10622,"timestamp":1786541341035,"change":-0.61,"changeRate":-0.006573,"amplitude":0.005927},"postHourTrading":{"tag":"盘后","latestPrice":92.8,"preClose":92.8,"latestTime":"19:34 EDT","volume":20096,"amount":1864869.8611,"timestamp":1786491245540,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.337333,"impliedVol":0.3557,"impliedVolPercentile":0.0717},"requestUrl":"/m/hq/s/BNTX","defaultTab":"news","newsList":[{"id":"1164864661","title":"BioNTech宣布管理层重大变动：Guido Oelkers将于2027年2月1日接任CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=1164864661","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1164864661?lang=zh_cn&edition=full","pubTime":"2026-08-04 19:06","pubTimestamp":1785841564,"startTime":"0","endTime":"0","summary":"路透社8月4日消息——BioNTech SE 发布第二季度财报，并宣布了一项关键人事任命。公司第二季度营收达到1.056亿欧元，但净亏损高达8.208亿欧元，每股亏损为3.24欧元。与此同时，BioNTech正式任命Guido Oelkers为首席执行官，该任命将于2027年2月1日正式生效。在业务进展方面，BioNTech迎来了利好消息——其针对新变异株的新冠疫苗已获得欧洲委员会批准。这一表态折射出BioNTech对市场动态的审慎态度。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","BK4588","BK4568","BNTX","BK4139","BK4551","BK4548","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148180088","title":"异动解读 | 财报显示净亏损超8亿欧元，BioNTech盘前大跌5.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=1148180088","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1148180088?lang=zh_cn&edition=full","pubTime":"2026-08-04 19:00","pubTimestamp":1785841253,"startTime":"0","endTime":"0","summary":"BioNTech SE(BNTX)今日盘前大跌5.78%，引起市场广泛关注。消息面上，公司公布的二季度财报显示，净亏损达8.208亿欧元，营收为1.056亿欧元。这一大幅亏损的业绩表现，显著低于市场预期，导致投资者信心受挫，股价承压。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BNTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167678049","title":"BioNTech第二季度营收达1.056亿欧元","url":"https://stock-news.laohu8.com/highlight/detail?id=1167678049","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1167678049?lang=zh_cn&edition=full","pubTime":"2026-08-04 18:58","pubTimestamp":1785841114,"startTime":"0","endTime":"0","summary":"BioNTech于8月4日公布第二季度财报。数据显示，该公司净亏损达8.208亿欧元，而营收则为1.056亿欧元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4139","BK4535","BK4588","BNTX","BK4548","BK4551","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103561229","title":"重点关注个股：Palantir、SpaceX、汇丰控股","url":"https://stock-news.laohu8.com/highlight/detail?id=1103561229","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1103561229?lang=zh_cn&edition=full","pubTime":"2026-08-04 17:28","pubTimestamp":1785835721,"startTime":"0","endTime":"0","summary":"**Palantir Technologies **：这家软件公司昨日盘后公布了强劲的财报，业绩表现亮眼，推动其盘前股价飙升逾15%。财报发布后，其股价微幅上涨。**汇丰控股 **：这家英国银行公布季度利润增长，并宣布了高达10亿美元的股票回购计划，但由于回购规模令部分投资者感到失望，其股价小幅走低。Segro股价小幅上扬，而安博盘前股价则基本持平。**辉瑞 、默沙东 、安进 与 BioNTech **：这些制药公司将在今日美股开盘前公布财报。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3581.USD","IE0004445239.USD","LU1066053197.SGD","LU0256863811.USD","AMDY","LU0122379950.USD","LU2360106780.USD","IE00BZ1G4Q59.USD","TM","LU0889565833.HKD","LU2108987350.USD","BK4023","BK4089","LU0320765489.SGD","LU2242649171.HKD","RWR","PSI","IE00BLSP4239.USD","LU2242646821.SGD","SG9999002232.USD","SGXZ99366536.SGD","LU2023250504.SGD","LU2242652126.USD","AMDG","LU1162221912.USD","BK4566","LU0456855351.SGD","AMDS","FRI","INDS","LU0274383776.USD","LEGR","LU1923623000.USD","LU2125154778.USD","PPTY","LU1069347547.HKD","LU1064131342.USD","IYR","SG9999001424.SGD","LU1983299246.USD","LU1291159041.SGD","GAMR","IE00BMPRXN33.USD","TEK","BMED","FAI","IE0001KFT4U8.USD","LU0889566641.SGD","LU2491050154.USD","AIQ","LU1988902786.USD","JDOC","LU1732799900.SGD","LU1732800096.USD","LU1989772923.USD","04332","LU1941712348.USD","CHAT","LU0321505868.SGD","LU0726765562.USD","IE00BJTD4V19.USD","URE","IE00BQXX3D17.EUR","SPCF","ERET","PLT","BK4571","AMDU","SGXZ51526630.SGD","USXF","IE0004445015.USD","LU1941712264.USD","LU2112291526.USD","LU2265009873.SGD","LU2125909593.SGD","VNQ","LU0823416689.USD","BP.UK","LU1061106388.HKD","SG9999015358.SGD","BK4567","LU0823421333.USD","LU0320765646.SGD","LU0965508806.USD","BIB","PLTG","AMGN","LU1804176565.USD","MCD","SPAX","BK4007","LU0081259029.USD","00005","AIPI","SSPC","BK4585","LU0128525689.USD","LU0130517989.USD","XLRE","BK4543","SGXZ57979304.SGD","LU0321505439.SGD","IE000M9KFDE8.USD","RNTY","BK4613","LU0109392836.USD","BK4512","LU0912757837.SGD","LU2290526834.HKD","REIT","WISE","IE0002270589.USD","LU2362540622.SGD","CLIM","HSBH","REET","IYRI","SG9999015341.SGD","LU1074936037.SGD","LU2491049909.HKD","BNTX","LU2362541513.USD","LU0823434583.USD","LU0127658192.USD","AMDL","LU1880398554.USD","PLTW","SG9999001176.SGD","JRE","SPCM","PAWZ","LU2458330169.SGD","QQQA","SPCX","IE00BQXX3F31.USD","DPRE","LU1894683264.USD","BK4554","LU0965509101.SGD","IE00BJTD4N35.SGD","LU2860962120.EUR","LU1201861249.SGD","BK4610","BK4521","LU1244550221.USD","LU1934455194.USD","LU1718418525.SGD","JPRE","LU0048584097.USD","PSR","SPOG","LU1093756325.SGD","CHPS","LU0942090050.USD","SG9999014567.USD","AVRE","LU0211331839.USD","DFAR","IE00BN8TJ469.HKD","LU1861220033.SGD","LU2360032135.SGD","SG9999014542.SGD","BK4207","LU0225284248.USD","LU0985481810.HKD","LU0203345920.USD","RITA","LU1989764664.SGD","LU0170899867.USD","SMHX","LU1057294990.SGD","LU0648001328.SGD","IE00B2B36J28.USD","LU0985320562.USD","LU0823421416.USD","LU0320765992.SGD","LU1232071149.USD","IE00B19Z3B42.SGD","BK4599","IE00BSNM7G36.USD","LU0133085943.USD","IE00BFTCPJ56.SGD","LU0052756011.USD","XLV","LU1267930227.SGD","LU1989771016.USD","LU2264538146.SGD","BK4547","BK4548","LU0965509010.AUD","IE00BFSS7M15.SGD","LU1880398471.USD","ICF","EYES","LU0082616367.USD","SPCQ","BK4141","IE00B5949003.HKD","LU2361045086.USD","LU0306806265.USD","BK4108","SG9999014575.USD","BK4534","WTRE","CRED","LU1244550577.SGD","LU1917777945.USD","PLTA","BK4605","LU1861559042.SGD","LU2361044949.HKD","SG9999003800.SGD","SHLD","BK4529","LU2089985449.USD","DAMD","TTEQ","BK4612","CNAV","LU0642271901.SGD","SPCH","03160","LU0211326755.USD","LU0795875169.SGD","BK4504","LU1861558580.USD","LU0689626769.HKD","AMDD","LU0070302665.USD","LU0266013472.USD","PLOO","LU0058720904.USD","LU0265550946.USD","SPCG","DFGR","LU1244550494.USD","PLTD","LU2361044865.SGD","PLTY","LU2458330243.SGD","IE00BJJMRX11.SGD","LU2106854487.HKD","LU0868494617.USD","XNTK","LU1267930813.SGD","SPRE","LU2236285917.USD","BK4551","AMDW","SPOT","LU1989772840.SGD","AMYY","BK4559","TBXU","LU0786609619.USD","IYH","LU0130102774.USD","IE00B1BXHZ80.USD","LU2133065610.SGD","LU2247934214.USD","VHT","LU2125909247.SGD","PLTZ","BK4550","LU1242518931.SGD","BK4224","BK4604","GUNZ","IE00BKVL7J92.USD","LU2433249047.HKD","MARS","LU0098860793.USD","IE00BJJMRZ35.SGD","LU2023250843.SGD","SMH","LU0477156953.USD","LU1023059063.AUD","SG9999002224.SGD","IE0009355771.USD","BK4532","LU1951200564.SGD","LU2362541273.HKD","ORBX","AMUU","PLTR","PPH","SG9999013999.USD","SOXX","IE00B19Z9P08.USD","BK4581","LU2347655156.SGD","LU2347655073.USD","LU0976567544.SGD","FTXH","LU2596442595.SGD","LU1861215975.USD","LU1951198990.SGD","BK4535","LU1883839398.USD","LU1929549753.HKD","LU0823434740.USD","BK4568","LU0198837287.USD","BK4592","LU1037948897.HKD","WARP","BK4209","IE00BFSS8Q28.SGD","IE00BMPRXR70.SGD","BAI","IHE","GDOC","BK4171","LU1303367103.USD","LU0310800965.SGD","LU1934455863.HKD","PLTU","IETC","IGV","DTRE","AIS","LU1316542783.SGD","LU2098885051.SGD","LU0211326839.USD","LU0792757196.USD","LU1066051225.USD","LU0251132253.USD","LU2089984988.USD","LU0006306889.USD","LU2250418816.HKD","IE00BQXX3C00.GBP","LU0124676726.USD","OZEM","LU1974910355.USD","IBBQ","BK4614","RWO","IE00BBT3K403.USD","IE00BZ9MQY76.HKD","BK4099","SG9999014559.SGD","ILDR","BK4588","SCHH","TRUR","LU1894683348.USD","LU0306807586.USD","PTIR","SG9999001440.SGD","IE0009356076.USD","VGSR","TRFK","LU1066051498.USD","IE00B7KXQ091.USD","LU1585245621.USD","LU0208291251.USD","AMD","LU1066051811.HKD","LU1989764748.USD","LU0795875086.SGD","IE00BJT1NW94.SGD","HRTS","LU1934455277.USD","LU0234572021.USD","IBB","LU1093756168.USD","LU2355687059.USD","PFE","TRUH","LU0980610538.SGD","LU1035773651.USD","LU0889565916.HKD","LU1116320737.USD","LU2279689827.SGD","LU2462591350.SGD","SG9999011175.SGD","IE00BJJMRY28.SGD","USRT","LU1430594728.SGD","LU0265550359.USD","IXJ","BK4573","LU2357627491.SGD","LU0289739699.SGD","LU0432979614.USD","MRK","LU0868494708.USD","BBH","FHLC","LU2896262040.SGD","LU0238689110.USD","RXL","LU2324357040.USD","LU0174119429.USD","IE0002141913.USD","LU1571399168.USD","LU2491050071.SGD","LU0106261372.USD","SOXY","LU2468319806.SGD","PLD","PLTI","LU2461242641.AUD","GQRE","LU1923622614.USD","LU0859254822.USD","PBE","LU1116320901.HKD","LU2125154935.USD","IE00B4R5TH58.HKD","LU0056508442.USD","PJP","LU0719512351.SGD","SG9999001176.USD","FREL","LU0417517546.SGD","ARTY","LOFF","LU0109394709.USD","IE00B3T34201.USD","IE00BMPRXQ63.HKD","LU0496365809.HKD","LU1803068979.SGD","IE00B894F039.SGD","LU0979878070.USD","LU1242518857.USD","LU1037948541.HKD","WUGI","BK4139","IE00BLSP4452.SGD","FTXL","BK4516","BK4575","LU1983260115.SGD","LU0203347892.USD","LU2360107168.USD","LU0861579265.USD","SGXZ81514606.USD","LU0390134368.USD","LU2931357623.SGD","WSPC","LU0225771236.USD","IE00B19Z9Z06.USD","LU1852331112.SGD","LU2054465674.USD","BK4533","PLYY","BBRE","HSBC","LU0210536198.USD","LU1699723380.USD","BK4555","LU0965509283.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172592420","title":"财报前瞻 ｜BioNTech SE本季度营收预计增5.96%，机构观点偏正面","url":"https://stock-news.laohu8.com/highlight/detail?id=1172592420","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1172592420?lang=zh_cn&edition=full","pubTime":"2026-07-28 09:31","pubTimestamp":1785202303,"startTime":"0","endTime":"0","summary":"BioNTech SE将于2026年08月04日公布新一季财报，市场聚焦营收恢复节奏、费用结构与研发推进节奏对盈利弹性的影响。市场一致预期显示，本季度BioNTech SE营收约1.58亿欧元，同比增长5.96%；调整后每股收益预计为-2.09欧元，同比下降4.18%；当前未见明确的毛利率与净利润/净利率的量化指引。市场对本季度营收预计同比增长5.96%，核心逻辑仍围绕季节性接种与配方更新带来的放量窗口。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻 ｜BioNTech SE本季度营收预计增5.96%，机构观点偏正面","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BNTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175800932","title":"Arbutus Biopharma与Genevant在加拿大提起诉讼，寻求对辉瑞/BioNTech的禁令及损害赔偿","url":"https://stock-news.laohu8.com/highlight/detail?id=1175800932","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1175800932?lang=zh_cn&edition=full","pubTime":"2026-07-16 19:33","pubTimestamp":1784201632,"startTime":"0","endTime":"0","summary":"Arbutus Biopharma Corporation与Genevant Sciences已在加拿大联邦法院提起诉讼，指控辉瑞与BioNTech SE侵犯其脂质纳米颗粒技术专利。该诉讼寻求法院颁布禁令，以阻止被告方继续使用相关专利技术，并要求其就侵权行为支付损害赔偿。诉状指出，辉瑞与BioNTech未经授权，在其新冠疫苗中使用了Arbutus和Genevant拥有的专有LNP递送技术。此次诉讼是Arbutus围绕其LNP知识产权发起的系列法律行动之一。案件的进展预计将受到生物技术及制药行业的密切关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BLSP4452.SGD","BK4551","BK4568","IE00B3T34201.USD","BK4139","SG9999001176.SGD","LU0289739699.SGD","LU0225771236.USD","LU1066053197.SGD","IE00BLSP4239.USD","LU0225284248.USD","LU0306806265.USD","BK4599","LU0321505868.SGD","LU0456855351.SGD","LU1894683264.USD","IE00B19Z3B42.SGD","BK4592","SG9999002232.USD","BK4550","BK4588","IE0002270589.USD","IE00B19Z3581.USD","BK4533","LU0170899867.USD","SG9999013999.USD","LU2596442595.SGD","LU1057294990.SGD","LU1023059063.AUD","IE00BBT3K403.USD","PFE","SG9999002224.SGD","LU1894683348.USD","ABUS","LU0234572021.USD","LU0321505439.SGD","SG9999011175.SGD","BK4007","SGXZ57979304.SGD","OZEM","LU0306807586.USD","BK4581","LU0058720904.USD","BK4534","BK4548","SG9999001176.USD","IE000M9KFDE8.USD","BK4585","LU0985481810.HKD","LU1883839398.USD","BNTX","LU0868494617.USD","LU1066051498.USD","LU0122379950.USD","SG9999003800.SGD","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127705711","title":"凯茜·伍德在股价下跌之际加倍押注SpaceX，继续抛售AMD股票","url":"https://stock-news.laohu8.com/highlight/detail?id=1127705711","media":"老虎资讯综合","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1127705711?lang=zh_cn&edition=full","pubTime":"2026-07-08 15:52","pubTimestamp":1783497176,"startTime":"0","endTime":"0","summary":"木头姐继续加仓SpaceX，减持AMD，押注商业航天、淡化芯片配置由“木头姐”Cathie Wood掌舵的ARK Invest周二继续调整投资组合，重点加码商业航天领域，同时减持半导体股。近期，市场对SpaceX的关注持续升温，焦点之一是公司IPO协议中的一项“30%规则”。值得一提的是，ARK周一已大举买入91.7万股SpaceX。市场目前聚焦AMD将于8月4日公布的业绩。事实上，ARK周一也已卖出约860万美元的AMD股票。","market":"us","thumbnail":"https://static.tigerbbs.com/0fb0479ff67cd3a760cdce353bcb60ed","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/0fb0479ff67cd3a760cdce353bcb60ed"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"凯茜·伍德在股价下跌之际加倍押注SpaceX，继续抛售AMD股票","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPCQ","DAMD","LLYX","BABX","SPCH","AMDY","BABO","BNTX","SPAL","KTUP","SPCM","KTOS","BABW","SPCF","LOFF","AMDD","AMUU","SSPC","AMDU","ELIS","LLII","ELIL","KBAB","XE","AMDL","BABA","LLYZ","AMDG","SNK","AMYY","SPCU","SPCG","AMDW","BABU","SPAX","LLY","SPCX","BBYY","AMD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1156020992","title":"辉瑞与BioNTech新冠疫苗获授权，将为6个月至11岁儿童统一使用10微克剂量","url":"https://stock-news.laohu8.com/highlight/detail?id=1156020992","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1156020992?lang=zh_cn&edition=full","pubTime":"2026-05-29 23:47","pubTimestamp":1780069665,"startTime":"0","endTime":"0","summary":"辉瑞公司与其合作伙伴BioNTech SE共同研发的新冠疫苗已获得授权，将面向6个月至11岁的所有儿童群体，统一采用10微克的剂量进行接种。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","LU1894683348.USD","BK4585","SG9999001176.USD","BK4588","BK4534","IE00BBT3K403.USD","LU0122379950.USD","BK4548","LU1883839398.USD","BK4007","LU0170899867.USD","LU0321505439.SGD","LU0456855351.SGD","SG9999011175.SGD","SG9999002224.SGD","SG9999002232.USD","LU0234572021.USD","BNTX","IE00B19Z3B42.SGD","LU0306807586.USD","SG9999013999.USD","IE00B19Z3581.USD","LU1894683264.USD","LU0225771236.USD","LU0289739699.SGD","LU1066051498.USD","LU0225284248.USD","BK4581","LU0306806265.USD","IE0002270589.USD","IE000M9KFDE8.USD","IE00BLSP4239.USD","LU0868494617.USD","SG9999001176.SGD","BK4568","BK4139","IE00BLSP4452.SGD","SGXZ57979304.SGD","BK4535","BK4533","LU0985481810.HKD","LU1023059063.AUD","BK4592","BK4550","PFE","LU1066053197.SGD","IE00B3T34201.USD","BK4599","LU0058720904.USD","LU0321505868.SGD","LU1057294990.SGD","SG9999003800.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168798534","title":"辉瑞与BioNTech SE准备根据FDA建议并在获批后供应2026-2027新冠疫苗配方：简报文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1168798534","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1168798534?lang=zh_cn&edition=full","pubTime":"2026-05-28 20:19","pubTimestamp":1779970796,"startTime":"0","endTime":"0","summary":"辉瑞与BioNTech SE已准备就绪，将依据美国食品药品监督管理局的建议，并在获得正式批准后，供应针对2026至2027年度的更新版新冠疫苗配方。相关计划细节载于公司提交的简报文件之中。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BLSP4239.USD","BK4592","LU0170899867.USD","LU0289739699.SGD","SG9999011175.SGD","LU1894683348.USD","LU1066051498.USD","LU0306806265.USD","BK4568","SG9999013999.USD","IE000M9KFDE8.USD","IE00B19Z3B42.SGD","LU0234572021.USD","SG9999003800.SGD","SGXZ57979304.SGD","BK4535","BK4534","SG9999002232.USD","LU0225771236.USD","LU0225284248.USD","LU1066053197.SGD","LU0985481810.HKD","BK4550","LU1023059063.AUD","BK4581","PFE","BK4588","LU0321505439.SGD","LU1894683264.USD","IE0002270589.USD","IE00B19Z3581.USD","LU0456855351.SGD","LU1057294990.SGD","BK4139","IE00BBT3K403.USD","IE00B3T34201.USD","IE00BLSP4452.SGD","BK4533","LU0321505868.SGD","BK4007","LU1883839398.USD","BK4585","SG9999001176.SGD","BK4599","LU0306807586.USD","BK4548","BK4551","LU0058720904.USD","SG9999001176.USD","SG9999002224.SGD","LU0868494617.USD","LU0122379950.USD","BNTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115280811","title":"BioNTech首季营业亏损6.775亿欧元 营收逊于预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1115280811","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1115280811?lang=zh_cn&edition=full","pubTime":"2026-05-05 19:08","pubTimestamp":1777979333,"startTime":"0","endTime":"0","summary":"生物技术公司BioNTech SE公布第一季度业绩，营业亏损达6.775亿欧元。当季营收为1.181亿欧元，大幅低于市场预估的1.67亿欧元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BNTX","BK4548","BK4535","BK4585","BK4551","BK4139","BK4568","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155749193","title":"异动解读 | BioNTech盘前大跌5.59%，因宣布关闭生产基地并转移疫苗生产","url":"https://stock-news.laohu8.com/highlight/detail?id=1155749193","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1155749193?lang=zh_cn&edition=full","pubTime":"2026-05-05 18:59","pubTimestamp":1777978765,"startTime":"0","endTime":"0","summary":"BioNTech SE (BNTX)今日盘前股价大跌5.59%，引起了市场的广泛关注。消息面上，BioNTech宣布将关闭位于德国和新加坡的多个生产基地，此举将影响多达1,860名员工。同时，公司计划将新冠疫苗的生产全面转移给合作伙伴辉瑞，德国本土将不再设立生产线。此外，BioNTech报告第一季度净亏损5.32亿欧元，较去年同期亏损有所扩大。公司表示将加大成本削减力度，预计到2029年每年可节省约5亿欧元，并计划回购价值高达10亿美元的本公司股票。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BNTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178819416","title":"BioNTech宣布2026年新冠疫苗生产将全面移交辉瑞 德国本土不再设生产线","url":"https://stock-news.laohu8.com/highlight/detail?id=1178819416","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1178819416?lang=zh_cn&edition=full","pubTime":"2026-05-05 18:45","pubTimestamp":1777977948,"startTime":"0","endTime":"0","summary":"BioNTech SE近日披露重大生产调整方案，计划于2026年内将新冠疫苗的完整生产流程转移至合作伙伴辉瑞旗下生产基地。这意味着该疫苗在德国境内的生产线将全面停止运作。\n此次战略调整标志着两家企业在疫情后期对疫苗生产布局的重新规划。作为曾经主导欧洲疫苗供应的德国生物技术公司，BioNTech将把生产重心完全转向技术研发与创新平台建设，而辉瑞将承担后续所有生产环节的全球供应链管理。\n业内观察人士指出，这一转变既反映了新冠疫苗需求常态化的市场现实，也体现出生物医药行业全球分工的深化趋势。两家企业未来将继续保持研发端的紧密合作，但生产职能的集中化将有助于优化成本结构并提升运营效率。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGXZ57979304.SGD","IE00B19Z3581.USD","LU1894683264.USD","IE000M9KFDE8.USD","BK4007","LU1066051498.USD","SG9999011175.SGD","LU1023059063.AUD","SG9999002232.USD","LU1883839398.USD","BK4534","BK4533","LU0058720904.USD","BK4568","BK4592","IE0002270589.USD","LU0868494617.USD","LU0985481810.HKD","SG9999001176.SGD","IE00BLSP4239.USD","SG9999001176.USD","BK4139","LU0225771236.USD","LU1894683348.USD","BK4548","BK4550","BNTX","IE00B3T34201.USD","BK4581","PFE","BK4535","LU0170899867.USD","LU0225284248.USD","LU0122379950.USD","BK4551","IE00BBT3K403.USD","SG9999003800.SGD","LU0306807586.USD","LU0456855351.SGD","LU1066053197.SGD","LU0321505439.SGD","LU0289739699.SGD","BK4588","SG9999002224.SGD","LU1057294990.SGD","BK4599","SG9999013999.USD","IE00BLSP4452.SGD","LU0306806265.USD","LU0321505868.SGD","IE00B19Z3B42.SGD","BK4585","LU0234572021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108621147","title":"BioNTech预计2029年全面实施成本削减措施后 每年将实现约5亿欧元经常性节约","url":"https://stock-news.laohu8.com/highlight/detail?id=1108621147","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1108621147?lang=zh_cn&edition=full","pubTime":"2026-05-05 18:45","pubTimestamp":1777977917,"startTime":"0","endTime":"0","summary":"德国生物技术公司BioNTech SE宣布，随着公司成本优化战略的全面落地，预计到2029年将实现每年约5亿欧元的经常性开支节约。\n这一重大成本削减计划将通过对研发管线、组织架构和运营效率的系统性优化来实现。公司表示，节约的资金将用于强化其在肿瘤学和传染病领域的创新药物研发。\nBioNTech强调，此次成本优化不会影响核心研发项目的推进，反而将通过资源重新配置提升研发效率。公司预计从2024年起将分阶段实施相关措施，并在2029年达成全面成效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4568","BK4548","BK4588","BK4551","BK4585","BK4535","BNTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183652207","title":"财报前瞻｜BioNTech SE本季度营收预计减5.87%，机构观点中性偏谨慎","url":"https://stock-news.laohu8.com/highlight/detail?id=1183652207","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1183652207?lang=zh_cn&edition=full","pubTime":"2026-04-28 09:34","pubTimestamp":1777340062,"startTime":"0","endTime":"0","summary":"BioNTech SE将于2026年05月05日盘前公布最新季度业绩，市场聚焦收入下行幅度与管线催化对情绪的拉动效应。公司当前主营由疫苗相关与合作收入构成，其中新冠肺炎疫苗为主要收入来源，贡献19.95亿欧元，占比69.53%，收入结构集中且对需求波动较敏感。上季度公司实现营收9.07亿欧元，同比下降23.75%；毛利率66.63%；归属于母公司股东的净亏损为3.05亿欧元，净利率为-33.61%；调整后每股收益为-1.25，同比下降215.74%。近期机构观点呈中性偏谨慎为主。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"财报前瞻｜BioNTech SE本季度营收预计减5.87%，机构观点中性偏谨慎","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BNTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121385572","title":"Trastuzumab Pamirtecan在2期子宫内膜癌队列中达到主要疗效终点","url":"https://stock-news.laohu8.com/highlight/detail?id=1121385572","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1121385572?lang=zh_cn&edition=full","pubTime":"2026-04-13 14:07","pubTimestamp":1776060460,"startTime":"0","endTime":"0","summary":"BioNTech SE与DualityBio的抗体偶联药物Trastuzumab Pamirtecan，在治疗表达HER2的复发性子宫内膜癌患者中，展现出具有临床意义的疗效。根据公布的数据，该药物在所有HER2表达水平中均表现出显著的抗肿瘤活性，并具备可控的安全性特征。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4139","BK4551","BK4588","BK4535","BNTX","BK4568","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624529418","title":"辉瑞和BioNTech停止在美国的一项新冠疫苗研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2624529418","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2624529418?lang=zh_cn&edition=full","pubTime":"2026-04-02 10:26","pubTimestamp":1775096794,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0868494617.USD","BK4534","LU0306807586.USD","LU1894683348.USD","SG9999001176.SGD","LU1023059063.AUD","BK4568","IE000M9KFDE8.USD","IE00BLSP4239.USD","LU0234572021.USD","LU1057294990.SGD","SGXZ57979304.SGD","LU1894683264.USD","IE00BBT3K403.USD","SG9999003800.SGD","BK4592","BK4581","LU0225771236.USD","LU0321505868.SGD","LU0289739699.SGD","LU0306806265.USD","SG9999001176.USD","SG9999011175.SGD","LU1066053197.SGD","LU0985481810.HKD","SG9999013999.USD","BK4550","IE00B19Z3581.USD","LU0058720904.USD","BK4588","IE00BLSP4452.SGD","LU0456855351.SGD","LU1066051498.USD","SG9999002232.USD","LU0122379950.USD","BK4533","IE00B19Z3B42.SGD","BK4599","PFE","BNTX","IE0002270589.USD","SG9999002224.SGD","BK4585","LU0225284248.USD","BK4007","LU0170899867.USD","LU0321505439.SGD","LU1883839398.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122810902","title":"辉瑞与合作伙伴BioNTech宣布：因招募缓慢将终止美国50至64岁健康成年人新冠疫苗研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1122810902","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1122810902?lang=zh_cn&edition=full","pubTime":"2026-04-01 23:35","pubTimestamp":1775057741,"startTime":"0","endTime":"0","summary":"辉瑞与合作伙伴BioNTech SE近日宣布，由于受试者招募进度未达预期，将终止针对美国50至64岁健康成年人群的新冠疫苗临床研究项目。两家公司透露，该年龄组志愿者的入组速度显著低于计划目标，导致研究难以按原定方案推进。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002270589.USD","BK4599","LU0868494617.USD","SG9999013999.USD","IE000M9KFDE8.USD","BK4581","BK4592","LU0321505868.SGD","LU1057294990.SGD","BK4548","PFE","BK4551","LU0306807586.USD","BK4534","BNTX","LU1894683264.USD","LU0985481810.HKD","LU0225771236.USD","LU0058720904.USD","LU1066051498.USD","LU1066053197.SGD","IE00BLSP4452.SGD","SG9999003800.SGD","SGXZ57979304.SGD","SG9999011175.SGD","BK4535","LU1894683348.USD","LU0289739699.SGD","BK4007","LU1023059063.AUD","LU0306806265.USD","LU0170899867.USD","IE00BLSP4239.USD","LU0456855351.SGD","LU0122379950.USD","BK4585","SG9999001176.SGD","IE00B19Z3B42.SGD","BK4533","BK4139","SG9999002232.USD","IE00BBT3K403.USD","LU0225284248.USD","SG9999002224.SGD","IE00B19Z3581.USD","SG9999001176.USD","BK4568","BK4588","BK4550","LU0234572021.USD","LU0321505439.SGD","LU1883839398.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618940472","title":"BioNTech创始人将离职创立新的mRNA企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2618940472","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2618940472?lang=zh_cn&edition=full","pubTime":"2026-03-11 21:11","pubTimestamp":1773234660,"startTime":"0","endTime":"0","summary":"BioNTech （BNTX）表示，联合创始人乌古尔·萨欣和厄兹莱姆·图雷齐将离职创办一家专注于mRNA的新公司，BioNTech将持有少数股权并提供某些技术授权。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：张俊 SF065","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-03-11/doc-inhqrrth2401842.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4588","BK4535","BK4568","BNTX","BK4551","SINA","BK4139","BK4548","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618951995","title":"美股异动 | 2026年收入指引低于预期 BioNTech(BNTX.US)暴跌超20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618951995","media":"智通财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2618951995?lang=zh_cn&edition=full","pubTime":"2026-03-10 22:46","pubTimestamp":1773153966,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周二，BioNTech盘初暴跌超20%，创4月25日以来最大跌幅，现报80.20美元。消息面上，此前该公司公布的第四季度调整后亏损以及2026年全年收入指引均低于分析师的预期。公司报告称，第四季度每股稀释后调整亏损为0.33欧元，而一年前每股盈利为1.79欧元，FactSet调查的分析师预计每股亏损为0.16欧元。对于2026年，该公司表示预计收入将在20亿欧元至23亿欧元之间，FactSet调查的分析师预计收入为27.5亿欧元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1412356.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BNTX","BK4535","BK4548","BK4585","BK4139","BK4551","BK4568","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191971117","title":"异动解读 | 创始人离职叠加业绩指引下调，BioNTech盘中暴跌21.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=1191971117","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1191971117?lang=zh_cn&edition=full","pubTime":"2026-03-10 21:45","pubTimestamp":1773150305,"startTime":"0","endTime":"0","summary":"BioNTech SE (BNTX) 今日盘中股价大幅下挫21.54%，引发了市场的广泛关注。消息面上，公司联合创始人兼核心领导层Ugur Sahin和Oezlem Tuereci宣布将于2026年底离开公司，以创立自己的新企业。这一关键人事变动引发了投资者对公司未来战略连续性与管理层稳定性的深度担忧，被认为是冲击股价的首要因素。与此同时，公司发布的第四季度财务报告显示营收同比下滑，净亏损扩大。更为关键的是，公司下调了2026年全年业绩指引，预计总收入为20亿至23亿欧元，远低于市场此前27.5亿欧元的预期。黯淡的财务前景与盈利挑战进一步加剧了市场的抛售情绪。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BNTX"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.biontech.com","stockEarnings":[{"period":"1week","weight":0.0159},{"period":"1month","weight":0.0143},{"period":"3month","weight":0.0062},{"period":"6month","weight":-0.1225},{"period":"1year","weight":-0.1506},{"period":"ytd","weight":-0.0252}],"compareEarnings":[{"period":"1week","weight":-0.001},{"period":"1month","weight":0.0207},{"period":"3month","weight":0.0381},{"period":"6month","weight":0.1311},{"period":"1year","weight":0.2117},{"period":"ytd","weight":0.13}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"BioNTech SE成立于2008年6月2日。该公司结合了数十年的免疫学，尖端治疗平台以及各种患者分析和生物信息学工具的开创性研究，开发针对癌症和其他疾病的个体化免疫疗法。该公司利用强大的新治疗机制，利用各种生物学靶点，利用每位患者免疫系统的力量，解决每位患者潜在疾病的独特分子特征。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":0.014337},{"month":2,"riseRate":0.142857,"avgChangeRate":-0.037906},{"month":3,"riseRate":0.571429,"avgChangeRate":0.057688},{"month":4,"riseRate":0.428571,"avgChangeRate":0.076942},{"month":5,"riseRate":0.571429,"avgChangeRate":0.029093},{"month":6,"riseRate":0.571429,"avgChangeRate":0.037799},{"month":7,"riseRate":0.857143,"avgChangeRate":0.124155},{"month":8,"riseRate":0.571429,"avgChangeRate":-0.040962},{"month":9,"riseRate":0.333333,"avgChangeRate":0.020492},{"month":10,"riseRate":0.666667,"avgChangeRate":0.023565},{"month":11,"riseRate":0.857143,"avgChangeRate":0.192937},{"month":12,"riseRate":0.285714,"avgChangeRate":-0.033371}],"exchange":"NASDAQ","name":"BioNTech SE","nameEN":"BioNTech SE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BioNTech SE(BNTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供BioNTech SE(BNTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"BioNTech SE,BNTX,BioNTech SE股票,BioNTech SE股票老虎,BioNTech SE股票老虎国际,BioNTech SE行情,BioNTech SE股票行情,BioNTech SE股价,BioNTech SE股市,BioNTech SE股票价格,BioNTech SE股票交易,BioNTech SE股票购买,BioNTech SE股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BioNTech SE(BNTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供BioNTech SE(BNTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}